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Abstract 
Bone repair using BMP-2 is a promising therapeutic approach in clinical practices, however, 
high dosages required to be effective pose issues of cost and safety. The present study 
demonstrates the potential of low dose BMP-2 treatment via tissue engineering approach, which 
amalgamates 3-D macro/microporous-nanofibrous bacterial cellulose (mNBC) scaffolds and low 
dose BMP-2 primed murine mesenchymal stem cells (C3H10T1/2 cells). Initial studies on cell-
scaffold interaction using unprimed C3H10T1/2 cells confirmed that scaffolds provided a 
propitious environment for cell adhesion, growth, and infiltration, owing to its ECM-mimicking 
nano-macro/micro architecture. Osteogenic studies were conducted by preconditioning the cells 
with 50 ng/mL BMP-2 for 15 minutes, followed by culturing on mNBC scaffolds for up to three 
weeks. The results showed an early onset and significantly enhanced bone matrix secretion and 
maturation in the scaffolds seeded with BMP-2 primed cells compared to the unprimed ones. 
Moreover, mNBC scaffolds alone were able to facilitate the mineralization of cells to some 
extent. These findings suggest that, with the aid of ‘osteoinduction’ from low dose BMP-2 
priming of stem cells and ‘osteoconduction’ from nano-macro/micro topography of mNBC 
scaffolds, a cost-effective bone tissue engineering strategy can be designed for quick and 
excellent in vivo osseointegration.  
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1. Introduction 
Bone fractures and injuries that cause large segmental bone defects do not heal naturally. To 
restore normal function, the damaged bone is replaced either by a complete artificial substitute 
(metallic or ceramic) or by harvesting the bone tissue from different areas of the same 
(autografting) or different person (allografting) or another species (xenografting). However, 
these practices face significant limitations due to the inadequate supply of donor tissue, pathogen 
transmission, graft rejection, surgeries at multiple sites, and poor osseointegration [1]. 
Nowadays, there is a paradigm shift in the practices of bone repair involving tissue 
engineering, which includes a 3-D biomaterial construct (known as scaffold), stem cells/stem 
cell-derived progenitor cells, and cellular signals (i.e. growth factors) to make biosynthetic bone 
grafts for efficient regeneration of damaged or fractured bones [1,2]. The scaffold is one of the 
key components of tissue engineering that serves as a template to support cell adhesion, 
proliferation, migration, and differentiation. This scaffold must be biocompatible and should 
mimic the topography and spatial structures of native extracellular matrices (ECMs) to provide 
the cues for regulating cell fate towards particular tissue type [3]. Therefore, significant attention 
is being paid to the materials and fabrication methods for developing ECM-mimicking scaffolds. 
To date, a number of scaffolds have been developed for bone tissue engineering using various 
natural and synthetic polymers by distinct techniques such as gas foaming, freeze-drying, 
particulate leaching, solvent casting, phase separation, electrospinning, etc. [1,4,5]. Amidst 
various techniques, electrospinning is considered superior as it fabricates nanostructured 
scaffolds that structurally emulate the natural ECM, but with the inherent disadvantage of limited 
scaffold thickness and pore size, which restrict three-dimensional cellular growth, resulting into 
suboptimal outcomes [6,7].  
Bacterial cellulose (BC), a polymer produced by a group of acetic acid bacteria owns a 
natural 3-D nanofibrils network. Meanwhile, it displays biomimetic mechanical properties with 
excellent biocompatibility, gas and fluid exchange capability, in situ moldability, and high water 
holding capacity [8,9]; making BC a superb scaffolding candidate for tissue engineering. 
However, the major downside of this naturally woven nanostructured scaffold is inadequate pore 
size ensuing from tightly packed BC nanofiber layers, which is hard for cells to penetrate [9]; 
thus hinders tissue in-growth and constrains its practical usage as a tissue engineering scaffold. It 
has been documented that pore size and pore-interconnectivity are crucial parameters in the 
development of scaffolds for tissue engineering because they allow cells to migrate and 
proliferate to the core of the implant as well as permit efficient diffusion of nutrients/metabolic 
waste, vascularization and remodeling to facilitate host tissue integration upon implantation 
[3,4]. Thus, introducing macro/micro porosity with apt interconnectivity in nanofibrous BC 
would lead to an ECM mimicking nano-micro-macro topography, which may suit well for its 
application in tissue engineering. 
Further, growth factors (GFs) play a vital role in tissue regeneration, thus, there are 
efforts to combine osteoconductive scaffolds with osteoinductive GF(s) for greater outcomes 
[3,10,11]. However, the covalent binding of GFs to scaffolds is time and cost intensive; in 
addition, due to arduousness in controlling the modification site, it may also obstruct the active 
sites of protein and hence impedes GF bioactivity [3,12]. On the other hand, non-covalent 
incorporation of GF(s) into scaffolds leads to an initial uncontrolled burst release, resulting into 
supraphysiological levels of GFs in the surrounding environment, which causes unwanted 
systemic abnormalities and local side effects such as ectopic bone formation, osteoclast-mediated 
bone resorption, mineral deposition in muscle tissues and inappropriate adipogenesis [3,13].  
Preconditioning (using growth factors, pharmacological agents, etc.) approaches in stem 
cell therapy is an emerging area of research, and several growing reports have publicized 
enhanced regenerative and repair potentials of preconditioned cells [14–17]. Thus, 
preconditioning of stem cells with appropriate GF(s) could prove to be a better strategy than 
GF(s) grafting on the scaffolds for bone tissue engineering applications, as it would minimize the 
side effects and shortcomings associated with the GFs grafting on the scaffolds as well as the 
treatment would be cost-effective. 
Considering all, the present study explores the potential of 3-D macro/microporous 
nanofibrous bacterial cellulose (mNBC) scaffolds seeded with BMP-2 preconditioned murine 
mesenchymal stem cells for bone tissue engineering to repair bone defects and nonunions. 
  
2. Materials and Methods 
2.1 Chemicals, culture media, and cells 
Dulbecco's Modified Eagle's medium (DMEM), fetal bovine serum (FBS), antibiotic-antimycotic 
solution, ascorbic acid, β-glycerophosphate, dexamethasone, bone morphogenetic protein-2 
(BMP-2), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), acridine orange 
(AO), ethidium bromide (EtBr), alizarin red and lysozyme were purchased from Himedia 
Laboratories, India. Hexamethyldisilazane (HMDS), phalloidin-FITC (fluorescein isothiocyanate 
labeled phalloidin), and 4′,6-diamidino-2-phenylindole (DAPI) were acquired from Sigma 
Aldrich. Murine mesenchymal stem cells (C3H10T1/2 cells) were obtained from National 
Centre for Cell Science, Pune, India. All the reagents were used as received unless specified 
otherwise.  
 
2.2 Preparation and characterization of 3-D macro/microporous-nanofibrous bacterial 
cellulose (mNBC) scaffolds 
Komagataeibacter europaeus SGP37, previously isolated in our laboratory [18] was used for 
bacterial cellulose (BC) production. BC pellicles were produced by cultivating the bacteria in 
modified Hestrin-Schramm (HS) medium and purified by boiling in 0.5 N NaOH, as reported 
earlier by our group [18]. For the fabrication of 3-D macro/microporous-nanofibrous bacterial 
cellulose (mNBC) scaffolds, emulsion freeze-drying method described by Xiong et al. [19], was 
adopted with minor modifications. Briefly, wet BC pellicles (containing refined nanofibrous 
network) were pulverized to a fine paste using a blender to prepare 2 wt% BC emulsion.  The 
emulsion was then poured into desired shape molds, frozen at -80 °C for 12 h and lyophilized to 
remove frozen water, leaving a highly porous nanofibrous 3-D matrix. The wt% of BC in the 
emulsion can be optimized for the desired porosity and pore size of the scaffolds. 
The microarchitecture of mNBC scaffolds was examined by field emission scanning 
electron microscopy (FE-SEM) (FEI Quanta 200 FEG) at an accelerated voltage of 15 kV, after 
coating the scaffolds with gold for 90 s. 
X-ray diffraction (XRD) analysis of mNBC scaffolds was carried out by Bruker AXS D8 
Advance powder X-ray diffractometer using Ni-filtered Cu-Kα radiation (λ = 1.54 Å). The data 
were collected in the range of 10-40° 2θ at 2° min-1 scan rate. The crystallinity index of the 
scaffolds and the allomorphic category of cellulose (Iα or Iβ form) after scaffold preparation, 
were determined as per the formulae described previously [18]. 
Thermogravimetric analysis (TGA) of the scaffolds was performed using 
Thermogravimetric/Differential Thermal Analyzer (EXSTAR TG/DTA 6300, Hitachi, Tokyo, 
Japan) over a temperature range of 25-600 °C at 10 °C min-1 scan rate (sample mass  ̴ 10.5 mg), 
under a nitrogen atmosphere with N2 flow rate of 200 mL min
-1. 
 
2.3 Degradation behavior of the scaffolds 
Degradation behavior of the mNBC scaffolds was observed in (i) phosphate-buffered saline 
(PBS) and (ii) phosphate-buffered saline containing 0.2 % lysozyme for 2 months. In brief, the 
scaffolds were incubated in the above-mentioned solutions at 37 °C. At predetermined time 
junctures (i.e. 15, 30, and 60 days), the scaffolds were removed, washed thrice with deionized 
water to remove salts, immersed in 100% ethanol for 2 h, which was then followed by drying at 
room temperature (RT) to constant weight. The weight loss of the scaffolds (as a measure of 
degradation) was observed by weighing the dried samples and any microstructural changes in the 
scaffold’s morphology were examined by FE-SEM. 
 
2.4 Cell culture 
Murine mesenchymal stem cells (C3H10T1/2 cells) were cultured in DMEM high glucose 
medium supplemented with L-glutamine, 10% FBS, 1% antibiotic-antimycotic solution 
(containing  10,000 U Penicillin, 10mg Streptomycin and 25µg Amphotericin B per mL) and 
propagated at 37 °C in a humidified atmosphere of 5% CO2. Once the cells reached 80-85% 
confluence, they were harvested using trypsin-EDTA solution, resuspended in fresh culture 
medium at desired density and used for seeding the scaffolds. 
 
2.5 Cell seeding and culture on 3-D mNBC scaffolds 
Before cell seeding, the scaffolds were sterilized by autoclaving at 121 °C for 20 min, followed 
by immersion in 70% ethanol under UV for 2 h. Subsequently, the scaffolds were washed twice 
with sterile PBS and submerged in cell culture medium for 12 h at 37 °C. After incubation, the 
extraneous culture medium (i.e. unsoaked medium) was removed and cells were seeded onto the 
scaffolds at predetermined cell density as follows, 
 
12-well sized scaffolds ( ̴ 18 mm diameter, ̴ 9 mm thickness) - 1,00,000 cells/scaffold using 200 
µL cell suspension 
24-well sized scaffolds ( ̴ 12 mm diameter, ̴ 6 mm thickness) - 50,000 cells/scaffold using 100 µL 
cell suspension 
48-well sized scaffolds ( ̴ 8 mm diameter, ̴ 4 mm thickness) - 30,000 cells/scaffold using 50 µL 
cell suspension 
 
Following cell seeding, the scaffolds were kept at 37 °C under a humidified atmosphere 
with 5% CO2 for initial cell attachment and the culture medium was added after 4 h of incubation 
to prevent unnecessary cell migration to the bottom of the plate. The plate was again placed in a 
humidified incubator with 5% CO2 at 37 °C for the duration of the experiments and the culture 
medium was replenished at each alternate day. 
 
2.6 Cell attachment 
For cell attachment studies, cell-seeded scaffolds (24-well sized) were incubated at 37 °C under a 
humidified atmosphere with 5% CO2 for 12 h. Following incubation, the scaffolds were washed 
twice with PBS and fixed using 4% formaldehyde for 30 min. After further washing with PBS, 
the scaffolds were dehydrated using a graded series of ethanol solutions (10%, 20%, 30%, 50%, 
70%, 90%, 100%(2x) for 5 min at each step), immersed in 100% HMDS and left to dry at RT. 
The dried cell-seeded scaffolds were sputter-coated with gold for 90 s and observed under FE-
SEM (Carl Zeiss, Ultra plus, Germany). 
 
2.7 Cell proliferation and viability 
2.7.1 MTT assay 
For this, 12-well sized mNBC scaffolds seeded with 1,00,000 cells/scaffold were cultured for up 
to one week and MTT assay was performed at predetermined time points (1, 4, and 7 days post-
seeding) according to the protocol mentioned elsewhere [20]. In brief, MTT solution was added 
to the scaffold-containing wells at a final concentration of 0.5 mg/mL at specified time points, 
and the plate was incubated in the dark for 4 h under a humidified atmosphere of 5% CO2 at 37 
°C. Post incubation, the solution in the wells was removed and the formazan crystals formed 
over the scaffolds were dissolved in DMSO by holding the plate on a shaker under darkness for 1 
h, which was then followed by measuring the absorbance at 570 nm. Scaffolds that were not 
seeded with cells were taken as a control to ignore the non-specific adsorption of MTT to the 
scaffolds. Besides quantitative measurements, visual and microscopic images of the formazan 
crystals over the scaffolds were also obtained using a normal digital camera and a CCD camera 
equipped with an inverted light microscope (Zeiss, Axiovert 25, Germany), respectively. 
 
2.7.2 Live/dead cell assay 
C3H10T1/2 cells (at seeding density of 1,00,000 cells/scaffold) were grown on  12-well sized 
scaffolds for 1, 4 and 7 days. At defined time points, the scaffolds were taken out, rinsed gently 
with PBS, and stained with equal volumes of acridine orange and ethidium bromide at a final 
concentration of 5 µg/mL for 30 s. Scaffolds were then visualized and imaged under an inverted 
fluorescence microscope (Carl Zeiss Axio Vert.A1, USA) to assess cell viability and 
proliferation. 
 
2.8 Cell infiltration 
At 1, 4, and 7 days of culture, the cell-seeded scaffolds (48-well sized) were removed from tissue 
culture plate, washed twice with PBS, and fixed in 4% formaldehyde for 30 min at RT. Post 
fixation, paraffin embedding of the scaffolds was done according to the protocol mentioned 
elsewhere with minor modifications [21]. Briefly, the scaffolds were dehydrated by escalating 
grades of ethanol (10%, 20%, 30%, 50%, for 10 min at each step and with 70%, 90%, 100%(2x) 
for 60 min at each step, at RT), treated with xylene (100% for 60 min(2x) at RT) and infiltrated 
with paraffin wax at 60 °C for 60 min(2x). The scaffolds were then embedded in the wax and cut 
transversely into  ̴ 0.5 mm thin slices using a microtome. Afterward, the slices were dewaxed 
using xylene, rehydrated using decreasing concentrations of ethanol (100%(2x),  90%, 70%, 
50%, H2O(2x) for 5 min at each step at RT), permeabilized with 0.1% Triton-X100 for 20 min 
and then stained with DAPI (0.3 µg/mL) for 20 min. The sections were then visualized and 
imaged under an inverted fluorescence microscope.  
 
2.9 Cell morphology and cytoskeleton arrangement 
Fluorescent staining of actin filaments was done to examine the morphology and cytoskeleton 
arrangement of cells grown over mNBC scaffolds. Briefly, 3-D cell-scaffold constructs were 
washed thrice with PBS and fixed using 4% formaldehyde for 30 min at RT. Following further 
washing with PBS, the cells were permeabilized using 0.1% Triton X-100 for 15 min at RT and 
stained with phalloidin-FITC (50 µg/mL) for 4h at RT under darkness. The constructs were again 
washed with PBS (3x) and counterstained with DAPI for 20 min at RT. Subsequently, the 
constructs were washed several times with PBS to remove the unbound dye and the cells were 
visualized and imaged using Confocal Laser Scanning Microscope (LSM 780, Carl Zeiss, 
Germany). Stacks of confocal images were obtained by optical slicing of the scaffolds in Z-
direction from top to bottom with 10 µm slice thickness up to 100 µm via Z-stack function of 
confocal microscopy. 
 
2.10 Osteogenic studies 
For osteogenic studies, four experimental groups of cell-scaffold constructs (Fig. 1) were 
maintained: 
 
(i) Group PM: Cells seeded mNBC scaffolds cultured in proliferation medium  
(ii) Group PMB: BMP-2 preconditioned-cells seeded mNBC scaffolds cultured in proliferation 
medium 
(iii) Group OM: Cells seeded mNBC scaffolds cultured in osteogenic medium  
(iv) Group OMB: BMP-2 preconditioned-cells seeded mNBC scaffolds cultured in osteogenic 
medium 
 
Prior to seeding, C3H10T1/2 cells were divided into two batches. One batch of cells was 
preconditioned with BMP-2 by incubating the cells (1,00,000 cells/ml) in proliferation medium 
(DMEM + 10% FBS) containing 50 ng/mL BMP-2 for 15 min, at 37 °C in a humidified 
atmosphere of 5% CO2 . The other batch of cells was used as such without any kind of treatment. 
Scaffolds (12-well sized) were then seeded with the respective batch of cells (2,00,000 
cells/scaffold) as depicted in Fig.1, and cultured in proliferation medium for two days at 37 °C 
under a humidified atmosphere of 5% CO2.  After two days, the culture medium was replaced 
with osteogenic media (DMEM, 10% FBS, 10nM dexamethasone, 50 μg/ml ascorbic acid, and 
10mM β-glycerophosphate) in groups OM and OMB, while groups PM and PMB were provided 
with proliferation media up to the duration of the culture. The culture media were changed every 
second day.  
 
2.11 Evaluation of mineralization/calcification 
2.11.1 Alizarin red S (ARS) staining 
For ARS staining, the cell-scaffold constructs were washed twice with PBS, fixed in 4% 
formaldehyde for 30 min, and then rinsed thrice with deionized water followed by staining in 
ARS solution (1%, pH- 4.3) for 20 min at RT. Excess stain was removed by submerging the 
scaffolds in deionized water overnight. The scaffolds were then dipped 20 times in acetone, 20 
times in acetone-xylene (1:1) solution, followed by clearing in 100% xylene for 15 min. The 
constructs were photographed using a normal digital camera and the microscopic images were 
obtained using a light microscope equipped with a CCD camera. 
The quantification of mineralization was performed using a colorimetric method [22]. 
Briefly, after clearing with xylene, the scaffolds were air-dried and added with 10% acetic acid 
(and crushed to some extent) followed by incubation at RT for 30 min under shaking to extract 
calcium bound ARS from the scaffolds. The mix obtained was transferred to a tube, vortexed for 
1 min, and heated to 85°C for 10 min, then ice-cooled for 5 min. The slurry was then centrifuged 
and the collected supernatant was mixed with 10% NH4OH at a ratio of 10:4, which was then 
followed by absorbance measurement at 405 nm. 
 
2.11.2 Visualization of Ca-P deposits under FE-SEM-EDS 
After 21 days of culture, the cell-scaffold constructs were processed for FE-SEM-EDS analysis 
according to the protocol detailed in Section 2.6. The samples were then examined under FE-
SEM (FEI Quanta 200 FEG), equipped with energy-dispersive x-ray spectroscopy (EDS) 
(EDAX TEAM Software), to visualize, map, and detect mineral deposits (Ca-P) over mNBC 
scaffolds grown under various groups.  
 
2.12 Statistical analysis 
Quantitative data are presented as mean ± standard deviation. Statistical comparisons were made 
using ANOVA followed by Tukey's post hoc test using Graph Pad Prism 6. The statistical 
significance was determined at p≤0.05. 
 
3. Results and Discussion 
3.1 Physicochemical characterization of 3-D mNBC scaffolds 
3.1.1 Macro and micro morphologies of 3-D mNBC scaffolds 
Macro/microporous-nanofibrous scaffolds are attracting widespread interest among researchers 
[23–25] due to their topological similarities with the natural ECM that facilitates high degree of 
cell adhesion and growth. Fig. 2 (a-c) depicts the macroscopic morphologies of the prepared 3-D 
macro/microporous-nanofibrous bacterial cellulose (3-D mNBC) scaffolds. The scaffolds 
represented are  ̴ 9 mm in thickness and  ̴ 18 mm in diameter. However, the size and shape of the 
scaffolds could be controlled by choosing the molds of specific dimensions to meet the desired 
size and shape requirements of the tissue. The micromorphology of the scaffolds was examined 
through FE-SEM (Fig. 2 d,e), which demonstrated that mNBC scaffolds had a highly porous 
microarchitecture compared to the native BC membrane (Figure S1) and displayed an irregular 
open-pore geometry with interconnected pore configuration formed by macro-pores (>100 µm, 
predominantly), micro-pores (<100 µm) and nano-pores (<100 nm).  
Pore size is a pivotal factor to be considered when designing scaffolds for tissue 
engineering, as pores facilitate the migration and proliferation of cells to the core of the implant 
as well as support vascularization. However, there are conflicting reports on the optimal pore 
size of scaffolds for bone tissue engineering. Scaffolds with mean pore sizes ranging from 20-
1500 µm have been applied for this purpose and it has been advocated that pores >300 µm 
enhance the osteogenic potential of scaffolds [23,26,27]. However, some reports have shown that 
microporosity (pore size <100 µm) plays a significant role in enhancing the osteogenic potential 
of scaffolds [28–30]. In this regard, Murphy et al. [31] put forward that micro-pores play a 
beneficial role in initial cell adhesion, but in the long run, improved cell infiltration and 
migration provided by macro-pores outweigh this effect, therefore deemed optimal for bone 
tissue repair. Thus, the nanofibrous structure, pore size heterogeneity and pores interconnectivity 
of the prepared mNBC scaffolds may be conducive to cell adhesion, proliferation, infiltration, 
and migration, which may lead to excellent osseointegration and vascularization upon 
implantation. 
 
3.1.2 X-Ray diffraction and thermogravimetric analyses of 3-D mNBC scaffolds 
X-ray diffraction analysis of mNBC scaffolds was carried out to observe any physical changes in 
the polymer after scaffold preparation. As shown in Fig. 2 f, the diffractogram showed three 
characteristic peaks at 2θ = 14.6, 16.2 and 22.2°, corresponding to (110), (110) and (200) 
crystallographic planes of the cellulose lattice, respectively [18,32], which was similar to the 
XRD profile of the native BC membrane (Figure S2). However, the crystallinity index (CrI) of 
the cellulose got decreased from 87.7 % (native BC membrane) to 54.66 % after scaffold 
preparation and the allomorphic category of the cellulose also changed from Cellulose Iα 
(triclinic lattice structure) to Cellulose Iβ (monoclinic lattice structure). This could be due to the 
disruption of cellulose chain assembly during the crushing process used for the preparation of 
scaffolds. 
Thermogravimetric analysis of mNBC scaffolds (Fig. 2e) also showed a similar TG-DTG 
profile to that obtained with native BC membrane (Figure S3) with three characteristic phases of 
weight loss [18]. However, the degradation of mNBC scaffolds started at  ̴ 285 °C and 33.19 % 
mass was remained at 350 °C, while the native BC membrane was stable up to  ̴ 295 °C and 
43.69 % residual mass was present at 350 °C. Decreased thermal stability of mNBC scaffolds 
could be attributed to their lowered crystallinity index, as the thermal degradation behavior is 
reported to be persuaded by the crystallinity and orientation of the BC nanofibers [32]. 
 
3.2 Degradation behavior of the scaffolds 
An ideal scaffold is required either to degrade or to be reabsorbed by the body after tissue 
regeneration. Being a polysaccharide, BC is unlikely to get affected by the proteases. Hence, the 
in vitro degradation behavior of mNBC scaffolds was examined in PBS and PBS containing 
lysozyme solutions, as lysozyme is present in almost all body fluids [33]. Although lysozyme 
mainly breaks the β-1,4 glycosidic linkage between the NAM and NAG units of peptidoglycan, it 
may also affect the β-1,4 glycosidic linkage of cellulose to some extent. Thus, mNBC scaffolds 
were incubated in PBS (pH 7.4) and PBS containing lysozyme (0.2%, pH 7.4) solutions 
separately, at 37 °C for 15, 30, and 60 days to assess the weight loss in scaffolds due to 
dissolution and degradation. No significant change in the weight of the scaffolds was noted in 
either of the solutions even after 60 days, as well as no deterioration in the scaffold’s 
microarchitecture was noticed either, except little crumpling (Figure S4), which indicates that the 
time needed for the degradation of mNBC scaffolds may be longer than the observation period. 
A study by Martson et al.  in a rat model reported that the cellulose sponges did not degrade 
completely even after 60 weeks. Although they were totally filled up with the connective tissues 
after 8 weeks of implantation, but the emergence of cracks and fissures, and slackening of the 
pore walls of the cellulose sponges were observed only after 16 weeks, hence they regarded it as 
a slowly degradable implantation material [34].  
Since cellulose is generally degraded in nature by microbial enzymes through hydrolase 
attack on the β-1,4 linkages, but these enzymes are not present in the mammals. In this case, 
cellulose degradation is likely to occur by an amalgamation of chemical, biological and 
mechanical processes. In other words, its degradation is controlled by several factors, such as its 
crystallinity, aggregation state, surface area, shape and morphology of the scaffolds, and the 
availability of physiological enzymes that attack the β-1,4 linkages [34,35]. Thus, the highly 
porous interconnected geometry of the scaffolds and the reduced crystallinity of the cellulose 
after scaffold preparation (as mentioned in Section 3.1.2) may be advantageous for its 
degradation after implantation. 
 
3.3 Cell studies 
3.3.1 Cell attachment, proliferation, viability and infiltration 
Cell behavior, such as adhesion, proliferation, spreading, and infiltration represents the initial 
phase of cell-scaffold communication which subsequently impacts the further events viz. 
differentiation and mineralization [36]. Although the biocompatibility of bacterial cellulose is 
well known, but the source of BC synthesis, the method used for BC scaffolds preparation, the 
scaffold characteristics and the cell type being used, make the preliminary cell–scaffold 
interaction studies essential for any further studies to begin with.  
In this regard, Fig. 3 displays the representative electron microscopic images of murine 
MSCs (C3H10T1/2 cells) adhered to mNBC scaffolds 12 h post-seeding. The images showed 
that the cells adhered well to the scaffold and maintained an extended fibroblast-like 
morphology. High-magnification images revealed that the cells adhered to the scaffold with their 
pseudopodium anchored on the walls of BC nanofibers, an indication of typical cell attachment 
and growth process. 
After adhesion, cells enter into the proliferation phase, hence, C3H10T1/2 cell 
proliferation on the mNBC scaffolds was investigated by MTT assay and the findings are 
summarized in Fig. 4a. MTT staining of cell-seeded scaffolds (Fig. 4a(i)) at various time points 
(days 1, 4, and 7) revealed that the cells were metabolically active (as indicated by purple color 
intensity) and gradually migrated throughout the scaffold during the time. Quantified data of 
MTT staining (Fig. 4a(ii)) showed a significant increase (P < 0.001) in the metabolic activity as a 
function of time for the duration of the experiment and represented a high cell viability and 
proliferation, indicating the biocompatible nature of mNBC scaffolds. To verify the results 
obtained from MTT assay, the viability and proliferation of C3H10T1/2 cells on mNBC 
scaffolds was further assessed by live/dead cell staining. The fluorescent images showing live 
cells in green and dead cells in red (Fig. 4b), reaffirmed the biocompatibility of mNBC scaffolds 
with hardly any detectable cell death. The cells continued to proliferate throughout the scaffold, 
as the results showed a rise in cell number over time, however, due to the 3-D nature of the 
scaffolds, the scattered cells could not be clearly imaged at a single focus but were visible on 
different planes. These findings are attributed to the highly porous interconnected geometry of 
mNBC scaffolds due to which the diffusion of nutrients and waste across the scaffold was 
ensured, rendering the cells to proliferate and be metabolically active. 
Rapidly attracting, recruiting, and dispersing the surrounding cells through the 3D matrix 
is one of the key requisites for the success of implantable tissue engineering scaffolds [37]. Cell 
ingress into mNBC scaffolds has thus been investigated during culture for up to 7 days by DAPI 
staining of cell nuclei in scaffold cross-sections. As delineated in Fig. 5a, the majority of seeded 
cells were present at/near the scaffold surface and a very small percentage of cells could be seen 
into the depth of the scaffold on day 1. However, by day 7, cells had infiltrated, proliferated, and 
homogeneously disseminated throughout the entire depth of scaffold; indicating the potential of 
mNBC scaffolds for tissue in-growth as well.  
The microscopic morphology of C3H10T1/2 cells on mNBC scaffolds was confirmed 
using CLSM, where the cells were stained with phalloidin tagged FITC for visualization of 
cytoskeletal processes and with DAPI to visualize nuclei. The results demonstrated a well 
spread, elongated, fibroblast-like morphology of C3H10T1/2 cells (Fig. 5b(ii)), consistent with 
the FE-SEM observation (Fig. 3). The cell infiltration inside the mNBC scaffolds was further 
confirmed by optical slicing of the scaffolds in Z-direction from top to bottom with 10 µm slice 
thickness through the Z-stack function of confocal microscopy (Fig. 5b(i)). Reconstructed 3-D 
projection images of the scaffold on day 4 post-seeding exhibited adequate growth, proliferation, 
and infiltration of cells, further supporting the fact that the mNBC scaffolds are ideal for tissue 
engineering applications. 
 
3.3.2 Osteogenic studies with BMP-2 preconditioned murine mesenchymal stem cells 
Bone regeneration is regulated by a cascade of molecular factors, however, BMPs (bone 
morphogenetic proteins) play a critical role in initiating the fracture repair cascade and primarily 
act by triggering osteogenic differentiation of osteoprogenitors and recruiting MSCs to the 
injured area [3]. In particular, BMP-2 and BMP-7 are considered the most potent osteoinductive 
cytokines, which are approved by FDA for the clinical practices [13]. However, the controlled 
delivery of BMPs to the site of injured bone tissue continues to be an arduous task due to the 
variable release profiles of BMPs from the carriers [3,13]. For instance, adsorbing BMPs to the 
implant surface leads to an early, uncontrolled, burst release of GF when exposed to the 
physiological environment. Immobilizing BMPs to the surface of the implant maintains a 
sustained presence of GFs; however, due to arduousness in controlling the modification site, 
covalent binding may block active sites of the protein and thus impedes the bioactivity of GF. 
Encapsulation and entrapment of BMPs evade the hitches associated with adsorption and 
immobilization, thus are the most popular way to deliver GFs; but many of these methods expose 
BMPs to harsh solvents, which may distort the conformational structure of the protein, thereby 
interferes with GF activity. All these hassles lead to the need for supraphysiological loading of 
BMPs (0.02-0.4 mg/mL in rodents, 0.75-2.0 mg/mL in nonhuman primates and 1.5-2.0 mg/mL in 
human clinical practices) in the carrier devices to achieve an efficacious outcome [13,38,39]. 
These doses, approximately 10 million times higher to that found in the body (pg/ml) have made 
BMP-based treatments very expensive (~$5,000 or more), and is believed to be responsible for 
many of the complications seen in BMP-based therapies, such as ectopic bone formation, native 
bone resorption, mineral deposition in muscle tissue, soft tissue swelling, etc. [13,39,40]. 
Therefore, novel systems for BMP delivery and the alternative approaches to harness optimal 
BMP effect at low BMP concentration, are continue to receive attention.  
Preconditioning strategies in stem cell therapy are currently catching the attention of 
researchers as a variety of preconditioning triggers such as sublethal insults (e.g. ischemia, 
anoxia, hypoxia), growth factors (e.g. SDF-1, ILGF-1, BMP-2), pharmacological agents (e.g. 
apelin, diazoxide, isoflurane) are found to increase the regenerative and repair potential of stem 
cells and stem cell-derived progenitor cells [14–17]. Thus, we preconditioned MSCs with a very 
low dose of BMP-2 (50 ng/mL) for 15 minutes prior to seeding on the scaffolds. Cell-seeded 
scaffolds were then cultured in complete media with/without osteogenic inducers (β-glycerol-2-
phosphate, dexamethasone and ascorbic acid) to determine whether BMP-2 preconditioning 
could modulate the stem cells behavior towards osteogenic differentiation. Two propositions led 
us to speculate that preconditioning of cells with BMP-2 could be sufficient to elicit osteogenic 
responses; (1) BMP-2 activity is mainly required at the initial stages of fracture healing, and (2) 
due to the short (in minutes) systemic half-life of BMP-2, its activity vanish gradually, even 
when administered locally in the scaffolds [41–43].  
One of the hallmarks of osteogenic differentiation is the formation of extracellular 
mineralized deposits of calcium and phosphorus salts, in which the anionic matrix molecules 
bind with Ca2+and PO4
3− ions, and thereafter serve as sites for nucleation and growth, leading to 
calcification [36]. Alizarin Red S staining was used to probe these mineral deposits on various 
groups of cell-seeded mNBC scaffolds at different time points (7, 14, and 21 days). Fig. 6(a-c) 
displays the optical and microscopic images of the ARS staining for the cell-seeded mNBC 
scaffolds and Fig. 6d depicts the respective quantitative data obtained after extracting ARS with 
10% acetic acid. Control scaffolds (without cells) incubated in differentiation medium, showed 
no positive stain (Figure S5), thus ruling out the point of dye absorption/adsorption by the 
scaffolds. 
The results demonstrated a variation in the extent of mineralization with culture time, 
culture media, and cell preconditioning. At day 7, the scaffolds cultured in osteogenic medium 
(i.e. Group OM and OMB) exhibited areas of diffuse and nodular mineralization, where group 
OMB (i.e. seeded with BMP-2 preconditioned MSCs) was slightly more intense than group OM 
(seeded with unprimed MSCs), however, it did not reach the statistical significance (P > 0.05). 
On the other hand, the scaffolds grown in proliferation medium (i.e. Group PM and PMB) 
showed a very low intensity diffused staining pattern, with no accountable difference between 
the groups, with reference to cell preconditioning. The similar trend was observed at day 14, but 
with relatively higher stain intensity in all the groups. However, some nodular mineralization 
was noticed in group PMB and the difference in the stain intensity of the scaffolds of group 
OMB and OM reached statistical significance (P < 0.01), suggestive of BMP-2 induced 
osteogenesis of preconditioned cells. At day 21, the stain intensity was much higher in all the 
groups, in fact, scaffolds of group OM and OMB completely turned red. Additionally, the stained 
deposits were witnessed throughout the scaffold depth from top to bottom, implying time 
dependence of cell mineralization to produce more Ca2+ binding sites for ARS. Moreover, the 
scaffolds seeded with BMP-2 preconditioned cells showed a higher score of stain intensity 
compared to the scaffolds seeded with unprimed cells, under both proliferation (P < 0.01) and 
osteogenic medium (P < 0.001) which further propounds the role of BMP-2 preconditioning in 
influencing osteogenesis of primed cells. The highest score of stain intensity in group OMB 
throughout the culture period is obviously attributed to the presence of DAG 
(dexamethasone/ascorbic acid/β-glycerolphosphate) in the culture medium, as DAGs are 
reported to enhance BMP-2 induced osteogenesis [44,45]. Interestingly, it was notable that 
mNBC scaffolds were able to facilitate mineralization of murine MSCs after 3 weeks of culture, 
even in the absence of osteogenic stimulants (DAG) and BMP-2 preconditioning. This may be 
due to the topographical characteristics of mNBC scaffolds, which might have provided 
osteogenic cues to the cells, leading to calcification. Thus, with the aid of BMP-2 primed cells 
and the intrinsic ability of the mNBC scaffolds to induce osteogenesis, a cost-effective bone 
tissue engineering strategy can be designed for quick and excellent in vivo osseointegration. 
A cross confirmation of the mineralized matrix over cell-scaffold constructs was done 
using FE-SEM followed by EDS, after 21 days of culture. The electron micrographs revealed 
that scaffolds were covered with the network of cells, extracellular matrix, and globular 
accretions of ~ 0.5-10 µm, suggestive of calcification (Fig. 7a) [46]. The size of the accretions 
was larger in the scaffolds of group OMB compared to the other groups, inferring enhanced 
calcification in group OMB. For verification of these accretive bodies to be of calcium 
phosphate, EDS mapping was performed (Fig.7b), which confirmed the accumulation of calcium 
phosphate at respective positions. The quantitative measures of EDS analyses also revealed the 
presence of calcium and phosphate in all the four groups of cell-scaffold constructs and the 
intensity of the peaks referring to these elements were found to be in the order 
OMB>OM>PMB>PM (Fig.7c). These results also depicted a similar trend in mineralization as 
obtained with ARS staining, suggesting that BMP-2 preconditioning of stem cells prior to 
seeding on scaffolds could be of potential benefit in tissue engineering of bone defects. 
Next, the cell-scaffold constructs were subjected to phalloidin- FITC and DAPI staining 
to find out how cells were behaving morphologically after 21 days of culturing on mNBC 
scaffolds (Fig. 8) as cell shape, cell area and cytoskeleton arrangement provide a unique way to 
characterize the differentiation directions [47]. The results revealed excellent adhesion and 
growth of cells on mNBC scaffolds even after 21 days of culture, however, cells looked 
overlapped and stacked on one another, and were found lining the walls of the scaffold pores. 
The cytoskeleton staining of cells grown under group PM displayed that some cells attained a 
broad shaped polygonal morphology while some were still elongated with spindle-shape (Fig. 8a, 
also refer Figure S6 for individual images of Z- stack). On the other hand, as expected, almost all 
the cells of group OM attained a broad polygonal morphology with a large increase in cell area 
(Fig. 8a and Figure S7), suggestive of their commitment towards osteogenesis [48].  
Cumulatively, these findings indicate that the combination of BMP-2 primed stem cells 
and 3-D macro/microporous nanofibrous bacterial cellulose scaffold could be a promising tissue-
engineering tactic to repair bone defects and nonunion, for which patient’s own MSCs could be 
isolated, preconditioned with BMP-2, seeded on the scaffold and thereafter implanted at the 
repair site for quick and efficient bone regeneration. Since a low dose of BMP-2 was used in this 
approach and that too affects only the cells stimulated ex vivo; thus, it would avoid the off-target 
adverse effects of high dose BMP-2 therapy as well as would cut down the cost of the treatment. 
Growing evidence supports increased regenerative potential of preconditioned cells in 
tissue repair and functional recovery. A study by Knippenberg et al. demonstrated that 
preconditioning of goat ADMSCs with 10 ng/mL BMP-2 for 15 min triggered the osteogenic 
differentiation of cells and preconditioning with BMP-7 under same conditions stimulated a 
chondrogenic phenotype [49]. Lysdahl et al. [15] found that preconditioning hBMMSCs with 20 
ng/mL BMP-2 for 15 min increased the proliferation and osteogenic differentiation of cells, 
while continuous exposure of cells with the same concentration of BMP-2 only increased the 
proliferation and did not make any difference in osteogenic differentiation. Martinez et al. 
demonstrated that ex vivo preconditioning of mouse BMMSCs with 2nM BMP-2 and 50 ng/mL 
Wnt3a for 24 hours, followed by seeding on gelatin/CaSO4 scaffolds, cooperatively enhanced 
the expression of osteogenic markers in vitro and bone regeneration in a critical-size calvarial 
defect mouse model [16]. A study by Watanabe and coworkers showed that preconditioning of 
rat BMMSCs with 5mM NAC (N-acetyl-L-cysteine) followed by seeding on collagen sponge 
significantly enhanced bone regeneration in critical-sized rat femur defect by strengthening 
BMMSCs resistance to apoptosis and senescence induced by oxidative stress during the acute 
inflammatory phase of injury [50]. 
Though preconditioning of stem cells or stem cell-derived progenitor cells have shown 
promising results in tissue repair and functional recovery, however, until now, in vitro 
preconditioning of cells for in vivo tissue regeneration has been challenging. Cells 
preconditioned for a longer period generally fail to integrate with the host, possibly due to the 
maturity of tissue; on the other hand, shorter preconditioning periods appear not to be sufficient 
in terms of clinically relevant outcomes [51]. Apart from this, many more hitches are associated 
with cell preconditioning for in vivo tissue regeneration; (1) will preconditioning factors exert 
adverse effects on cells, (2) will stem cells acquire tumorigenicity after preconditioning, (3) what 
should be the safe dose of these factors? All these apprehensions need to be clarified before 
proceeding further in this direction. 
 
4. Conclusions 
Collectively, 3-D macro/microporous-nanofibrous bacterial cellulose (mNBC) scaffolds were 
prepared and applied to direct osteogenic differentiation of low dose BMP-2 primed murine 
mesenchymal stem cells, in order to develop an efficient and cost-effective bone tissue 
engineering strategy. The ECM-mimicking nano-macro/micro architecture of mNBC scaffolds 
provided an excellent environment for cell adhesion, growth, infiltration, and to some extent 
osteodifferentiation also, making it ideal for bone tissue engineering. Osteogenic studies 
demonstrated significantly enhanced bone matrix secretion and maturation when the scaffolds 
were seeded with BMP-2 primed cells compared to the unprimed ones and a synergistic effect 
towards calcification was seen when BMP-2 primed-cells-scaffold constructs were provided with 
osteogenic stimulants (DAG) during the culture. However, additional studies at molecular level 
are required to corroborate these findings, as well as further studies to elucidate the underlying 
mechanisms, including intracellular signal transduction pathways are warranted.  
Nevertheless, these exploratory findings suggest that adopting low dose BMP-2 
preconditioning of stem cells in a bone tissue engineering strategy may provide a promising 
solution to alleviate the economic and negative impact of high dose BMP-2 grafting on scaffolds, 
as well as may offer a paradigm to design strategies for stem cell fate direction in other arenas of 
regenerative medicine. 
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Figures 
 
 
 
 
Fig. 1 Cell culture strategy for osteogenic studies 
 Fig. 2 (a-c) Visual aspects of mNBC scaffold in terms of its three dimensionality and size; (d-e) 
microscopic morphology of mNBC scaffold at (d) 50 X and (e) 5k X magnifications showing a 
macro/microporous-nanofibrous architecture;  (f) X-ray diffraction profile and (g) TG-DTG 
curve of mNBC scaffolds 
 Fig. 3 FE-SEM micrographs showing C3H10T1/2 cells (murine MSCs) attachment on 3-D 
mNBC scaffolds at (a) 1kX and (b) 5kX magnifications (cells were located on the surface 
(yellow arrow) as well as within the pores (cyan arrow) of the scaffold) 
 Fig. 4 (a) MTT assay of C3H10T1/2 cells seeded mNBC scaffolds at days 1, 4, and 7. Panel (i) 
illustrates the visual and microscopic aspects of the MTT assay (inset displays the magnified 
view of formazan crystals) showing a rise in purple colour intensity over time due to an increase 
in metabolically active cells. Panel (ii) depicts the histogram representing quantitative data (n=6; 
P < 0.001) of MTT assay [Scale bar = 100 µm; US: Upper Side; LS: Lower Side of the scaffold]. 
(b) Live/dead cell staining of C3H10T1/2 cells seeded mNBC scaffolds at days 1, 4, and 7. Live 
cells were stained green by acridine orange (AO) and dead cells were stained red by ethidium 
bromide (EtBr) [Scale bar = 50 µm]. 
 
 
 
 
 
 
 Fig. 5 (a) C3H10T1/2 cells infiltration into 3-D mNBC scaffolds at days 1, 4, and 7, 
demonstrated by DAPI staining of cell nuclei in scaffold transverse-sections. The sketched white 
lines on the fluorescent images are intended to set out the outer edges of the scaffold [Scale bar = 
200 µm]. (b) Confocal micrographs of phalloidin-FITC and DAPI stained C3H10T1/2 cells 
cultured on 3-D mNBC scaffolds: Panel (i), 3-D projection of Z-stack images from surface to 
bottom of the scaffold (up to 70 µm); Panel (ii), cytoskeletal morphology of C3H10T1/2 cells on 
mNBC scaffolds (from selected rectangle area).  
 
 Fig. 6 Alizarin red staining of C3H10T1/2 cells seeded mNBC scaffolds at (a) day 7, (b) day 14 
and (c) day 21. Panel (i) and (ii) shows the visual and microscopic images of ECM 
mineralization on the scaffolds, respectively. Respective quantitative data (d) obtained after 
extracting ARS from the stained scaffolds is presented as mean ± SD based on at least triplicate 
observations from two independent experiments. (PM: proliferation media; PMB: proliferation 
media+BMP-2 preconditioning of cells; OM: osteogenic media; OMB: osteogenic media+BMP-
2 preconditioning of cells; 3-D: 3-dimensional; US: upper side of the scaffold; LS: lower side of 
the scaffold) 
 
 
 
 
 
 
 Fig. 7 FE-SEM and EDS analyses of C3H10T1/2 cells-seeded mNBC scaffolds after 21 days of 
culture: (a) FE-SEM micrographs showing mineralized matrix, (b) EDS mapping confirming the 
presence of Ca and P in the accretions (Cyan blue dots- Ca; Yellow dots- P), (c) EDS spectra 
showing quantitative measures of Ca and P. (PM: proliferation media; PMB: proliferation 
media+BMP-2 preconditioning of cells; OM: osteogenic media; OMB: osteogenic media+BMP-
2 preconditioning of cells)  
 
 Fig. 8 Cellular morphology and cytoskeleton arrangement of C3H10T1/2 cells grown on 3-D 
mNBC scaffolds after 21 days of culture in (a) proliferation and (b) osteogenic medium. Actin 
cytoskeleton is shown in green by fluorescent staining with phalloidin-FITC and nuclei are 
shown in blue by DAPI staining. (These images are 2-D reconstruction of individual Z-stack 
images (provided as supplementary data) obtained by the optical slicing of samples in the Z-
direction through Z-stack confocal microscopy) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graphical Abstract 
 
 
 
 
 
 
 
 
 
 
 Annexure A. Supplementary data 
 
 
Figure S1 Microarchitecture of native BC membrane 
 Figure S2 X-ray diffractogram of native BC membrane 
 
 
 
 
Figure S3 TG-DTG curve of native BC membrane 
  
Figure S4 (a) Degradation behavior of mNBC scaffolds as a function of time; (b) microstructural 
morphology of mNBC scaffolds after two months of incubation in PBS-Lys at 37 °C. Values are 
represented as mean ± SD (n = 3) (PBS: Phosphate buffered saline; PBS-Lys: Phosphate 
buffered saline containing 0.2% lysozyme). 
 
 Figure S5 Alizarin red staining of mNBC scaffolds without cells. Panel (i) and (ii) shows the 
visual and microscopic images of the scaffolds, respectively. (3-D: 3-dimensional; US: upper 
side of the scaffold; LS: lower side of the scaffold) 
 Figure S6 Confocal micrographs showing individual Z-stack images of phalloidin-FITC and 
DAPI stained C3H10T1/2 cells cultured on 3-D mNBC scaffolds after 21 days of culture in 
proliferation medium (optical slicing was done with 10 µm slice thickness up to 100 µm) 
 
 
 Figure S7 Confocal micrographs showing individual Z-stack images of phalloidin-FITC and 
DAPI stained C3H10T1/2 cells cultured on 3-D mNBC scaffolds after 21 days of culture in 
osteogenic medium (optical slicing was done with 10 µm slice thickness up to 100 µm) 
 
 
